MicroByre
Team size: 11 - 50
Sector: Transportation and mobility
About MicroByre
Company revenue: US$ 10 - 50 million
Investors: Bioeconomy Capital, Earthshot Ventures, PRIME Coalition, Prime Impact Fund
Company stage: Series A
MicroByre is a biotechnology company that specializes in microbiology, synthetic biology, molecular biology, and computational biology. It domesticates and then genetically engineers otherwise reluctant, recalcitrant, and rebellious bacteria. It was founded in 2017 and headquartered in California, United States.